FDA Warns Against Overuse of TPOXX Monkeypox Drug
FRIDAY, Sept. 16, 2022 (HealthDay News) — U.S. health officials are advising doctors not to overuse the only antiviral for monkeypox because there is a risk for the virus mutating and rendering the drug useless.TPOXX (tecovirimat) works by targeting …
Learn MoreDupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years
FRIDAY, Sept. 16, 2022 (HealthDay News) — For children younger than 6 years, dupilumab significantly improves signs and symptoms of atopic dermatitis, according to a study published in the Sept. 17 issue of The Lancet.Amy S. Paller, M.D., from the Fe…
Learn MoreTwelfth Version of Living Guideline Issued for Drugs for COVID-19
FRIDAY, Sept. 16, 2022 (HealthDay News) — In the living guideline developed by the World Health Organization and published in The BMJ, recommendations on drug options for the treatment of COVID-19 have been updated.Arnav Agarwa, M.D., from McMaster U…
Learn MoreTwelfth Version of Living Guideline Issued for Drugs for COVID-19
FRIDAY, Sept. 16, 2022 (HealthDay News) — In the living guideline developed by the World Health Organization and published in The BMJ, recommendations on drug options for the treatment of COVID-19 have been updated.Arnav Agarwa, M.D., from McMaster U…
Learn MoreBedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
FRIDAY, Sept. 16, 2022 (HealthDay News) — For patients with extensively drug-resistant (XDR) tuberculosis, the overall risk-benefit ratio seems to favor patients receiving the bedaquiline-pretomanid-linezolid regimen with linezolid at a dose of 600 m…
Learn MoreNeoadjuvant Pembrolizumab Not Tied to More AEs in Oral Cavity SCC
THURSDAY, Sept. 15, 2022 (HealthDay News) — Among patients with local regionally advanced oral cavity squamous cell carcinoma, rates of postoperative adverse events appear to be similar for those receiving neoadjuvant pembrolizumab or standard-of-car…
Learn MoreAdjunct Minocycline No Benefit for Treatment-Resistant Depression
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — For patients with treatment-resistant depression (TRD), minocycline as add-on to antidepressant treatment as usual does not reduce depressive symptoms, according to a study published online Sept. 14 in JAM…
Learn MoreData Support Continued Access to Tecovirimat for Monkeypox
MONDAY, Sept. 12, 2022 (HealthDay News) — The data support continued access to tecovirimat for treatment of monkeypox virus infection, with subjective improvement seen at a median of three days after initiation of treatment, according to research pu…
Learn MoreCemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC
MONDAY, Sept. 12, 2022 (HealthDay News) — Fifty-one percent of patients receiving neoadjuvant therapy with cemiplimab for resectable stage II, III, or IV (M0) cutaneous squamous cell carcinoma had a pathological complete response, according to a stu…
Learn MoreDogs Have Died After Licking a Common Chemotherapy Cream, FDA Warns
FRIDAY, Sept. 9, 2022 (HealthDay News) — Your dog may like to lick your hand or face, but if you’re using a chemotherapy cream that treats certain skin conditions, you should not allow it, the U.S. Food and Drug Administration advises.The medication …
Learn More